Steven Cohen's TOI Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 69,275 shares of The Oncology Institute, Inc. (TOI) worth $246,619, representing 0.00% of the portfolio. First purchased in 2023-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in TOI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 69,275 shares. Largest reduction occurred in Q3 2023, reducing 14,147 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's The Oncology Institute (TOI) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Oncology Institute (TOI) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +69,275 | New Buy | 69,275 | $3.56 |
| Q3 2023 | -14,147 | Sold Out | 0 | $0.00 |
| Q2 2023 | +14,147 | New Buy | 14,147 | $0.55 |
Steven Cohen's The Oncology Institute Investment FAQs
Steven Cohen first purchased The Oncology Institute, Inc. (TOI) in Q2 2023, acquiring 14,147 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held The Oncology Institute, Inc. (TOI) for 3 quarters since Q2 2023.
Steven Cohen's largest addition to The Oncology Institute, Inc. (TOI) was in Q4 2025, adding 69,275 shares worth $246,619.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 69,275 shares of The Oncology Institute, Inc. (TOI), valued at approximately $246,619.
As of the Q4 2025 filing, The Oncology Institute, Inc. (TOI) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in The Oncology Institute, Inc. (TOI) was 69,275 shares, as reported at the end of Q4 2025.